myo-Inositol is synthesized de novo in cells through the conversion of glucose 6-phosphate to inositol 1-phosphate, followed by dephosphorylation. 1, 2) The former reaction is rate-limiting and is mediated by myo-inositol 1-phosphate synthase (IP synthase; E.C. 5.5.1.4), and the latter by inositol monophosphatase. myo-Inositol-containing compounds, such as inositolcontaining lipids and inositol polyphosphates, play important roles in several biological processes. They act as critical second messengers in signal transduction pathways, serve as key compounds of cellular membranes, and play crucial roles in DNA recombination, gene expression, protein phosphorylation, vacuolar morphology, telomere length maintenance, and so on. 3) IP synthase is widely distributed in prokaryotes to eukaryotes. 4) In the yeast Saccharomyces cerevisiae, INO1 encodes IP synthase, and the regulation of INO1 expression has been studied in detail. INO1 gene expression is highly regulated by inositol in media, almost completely repressed in a medium containing inositol, and de-repressed in inositol-free medium. It is dependent on the transcription activator factor composed of INO2 and INO4 gene products. 5) These two proteins, Ino2p and Ino4p, form a hetero-dimer, bind to UASINO1, a consensus sequence present in the INO1 promoter region, and enhance the expression of the INO1 gene. When inositol is present in the medium, the negative regulatory factor, encoded by OPI1, prevents the action of the Ino2p/Ino4p complex.
On the other hand, little is known about the regulatory mechanism by which the human IP synthase gene is regulated. Human IP synthase is encoded by ISYNA1 (hereafter we refer to this as hINO1), and Seelan et al. reported that E2F1 triggered expression of the hINO1 gene, as a transcription activator. 6) From the GC-rich nucleotide sequence of the promoter region of hINO1 and the results of computer analyses, they predicted that E2F1 is a transcription factor for hINO1. Then they presented evidence that E2F1 binds to and activates the promoter of hINO1, by gel-shift assays and reporter gene assays. Based on a series of promoter deletion constructs, they proposed a minimal promoter region for the hINO1 promoter, but also mentioned that wide-range regions of the hINO1 promoter are necessary for the expression of hINO1 in addition to the minimal promoter region.
The immediate-early gene pip92 (also known as Chx1 or IER2) has been cloned independently from serumstimulated Balb/c 3T3 fibroblasts 7) and from activated T-lymphocytes treated with cycloheximide. 8) Its human homolog, ETR101, was also cloned from the myeloid leukemia cell line HL-60. 9) pip92 mRNA is rapidly and transiently induced by sera, EGF, NGF, PDGF, FGF, TPA, and membrane depolarization, 10) and functionally implicated in the neuronal differentiation process. The serum response element is the major regulatory element located in the pip92 promoter, which is recognized by the serum response factor and transcription factors of the Ets family.
11) pip92 encodes a short-lived protein (pip92) exhibiting no significant sequence similarity to any other known protein. The predicted protein is rich in proline, serine, and arginine residues, and has two nuclear localization signals, and patches similar to ones in the jun-D, jun-B, and c-jun gene products, 8) Although the pip92 protein was found to be present in the cytoplasm on cell fractionation, 7) it was also found that it is selectively expressed in the nucleus as a fusion protein with green fluorescent protein. 12) pip92 protein has multiple phosphorylation sites, suggesting possible post-translational activation by protein kinase C due to its inducibility by TPA.
The predicted amino acid sequence of the ETR101 gene product (ETR101) is very similar to that of pip92 protein. Seventy-seven percent of the amino acid residues encompassing the entire region are identical in the two proteins, and two nuclear localization signals and y To whom correspondence should be addressed. Tel: +81-948-29-7822; Fax: +81-948-29-7801; E-mail: nikawa@bio.kyutech.ac.jp many phosphorylation sites are conserved. 9) ETR101 mRNA is also induced, like several other immediateearly genes, by TPA and serum growth factors. Many studies on the transcriptional regulation of ETR101, as well as pip92, have been reported. On the other hand, little is known about the function of the encoded protein, though all of the observations presented above suggest the possibility that the ETR101 protein, and also the pip92 protein, are nuclear DNA-binding proteins that probably regulate transcription.
Here we report functional analyses of the ETR101 protein using a yeast system. First we constructed a yeast Saccharomyces cerevisiae strain in which the promoter region of the PSS1 gene was replaced with that of the hINO1 gene. The gene product of PSS1, phosphatidylserine synthase, is essential for the de novo synthesis of phosphatidylcholine in yeast. Thus when expression of the PSS1 gene is low, the yeast cell must synthesize phosphatidylcholine via the CDP-choline pathway, and hence requires choline for its growth. When genes encoding transcriptional activators for hINO1 were introduced into this yeast strain, the transformants grew without choline in the medium. We transformed the yeast strain with a human cDNA library in which cDNAs were under the control of the yeast ADH1 promoter. Next we obtained two human cDNAs, which turned out to be E2F1 and ETR101. E2F1 protein is known as a transcription factor that regulates cell cycle progression, and has been reported to bind to and activate the hINO1 promoter by Seelan et al., 6) as mentioned above. We report here that the ETR101 gene product also functions as a transcriptional activator for the hINO1 promoter.
Materials and Methods
Yeast strains and culture. The following yeast strains were used: D452-2 (MAT leu2 ura3 his3), PSShI1p (MAT leu2 ura3 his3 URA3::hINO1pro::PSS1), PSS7 (MAT leu2 ura3 his3 URA3::GAL10pro::PSS1), PhI-I2H (MAT leu2 ura3 his3 URA3::hINO1pro::PSS1 Áino2::HIS3), INO2H (MAT leu2 ura3 his3 Áino2::HIS3), INO4H (MAT leu2 ura3 his3 Áino4::HIS3), and KUMI24 (MAT leu2 ura3 his3 Áino2::URA3 Áino4::HIS3). Yeast cells were cultured aerobically in either YPD or synthetic minimal media with shaking at 30 C. The compositions of the YPD and inositol-free minimal medium M-i were as described previously. 13) Inositol and choline were added to the minimal media at concentrations of 0.1 mM and 0.2 mM respectively. When necessary, L-leucine, L-histidine, and uracil were each added to the culture media at concentration of 20 mg/ml.
Construction of gene-manipulated yeast strains. Strain PSS7, in which the promoter region of PSS1 was replaced with that of GAL10, was created in the same manner as strain UGH303, as described previously, 14) except that the PSS1 gene was used instead of the HAC1 gene. The primers used in construction of the promoter-replaced PSS1 DNA fragment were 5 0 -ATCAAGGTCTACATGTAAG-3 0 plus 5 0 -GATGGGTCCATGTGAAAGC-3 0 and 5 0 -ATGGTTGAATCAGAT-GAAG-3 0 plus 5 0 -CTCAGACAACTTACAATAG-3 0 . Strain PSShI1p, in which the promoter region of PSS1 was replaced with that of the hINO1 gene, was constructed as follows: The hINO1 promoter DNA fragment was amplified by PCR with primers 5 0 -GCCCTGCCTGTGAGTTCC-3 0 and 5 0 -GCGGCGGCGGACAGC-GCG-3 0 (hINO-B), and human genomic DNA (CN Bioscience Inc., Darmstadt, Germany) as template. An approximately 1-kbp PCR product was inserted into pCR2.1-TOPO (Invitrogen, Carlsbad, CA) to yield TOPOhI1p. The nucleotide sequence of the PCR product inserted was confirmed by sequencing terminal DNA sequences of about 300 bp at both ends. Plasmid TOPOhI1p was digested with AhdI and EcoRI, and then treated with the Klenow enzyme, and an approximately 0.9-kbp DNA fragment containing the INO1 promoter region was inserted into the HincII site of pT-URA3. pT-URA3 is a plasmid containing the URA3 gene in creating PCR-mediated URA3-disrupted gene fragments. 15) The plasmid pT-URA3hI1p thus obtained was digested with AhdI, and an approximately 2.1-kbp DNA fragment, which contained the URA3 gene and the promoter region of the hINO1 gene with T overhangs at its 3 0 -ends, was used to replace the yeast chromosomal PSS1 promoter by the same method as that used in the construction of strain PSS7.
Strains having the HIS3-disrupted INO2 and INO4 genes were constructed by the method used in the synthesis of marker-disrupted alleles of yeast genes. 15) cDNA cloning. The human cDNA library used was constructed from glioblastoma cells on a yeast multi-copy vector, pADANS, which contains the yeast ADH1 promoter, a following small part of the coding region, the ADH1 terminator, and the yeast LEU2 gene as a selectable marker. 16) Strain PSShI1p was transformed with the cDNA library, and colonies that grew on minimal medium supplemented with histidine alone were selected. Plasmids were recovered from the transformants and used in E. coli transformation. Two clones, AA2M02 and AA2M14, were isolated. AA2M02 and AA2M14 contained cDNAs for ETR101 and E2F1 respectively.
Plasmid construction. YEpM4 17) and pHV1 18) are 2-mm DNA-based vectors containing the LEU2 and HIS3 genes as selectable markers respectively. pHV1ÁB is a derivative of pHV1, which was constructed as follows: One of the two BamHI sites within the pHV1 vector was cut by partial BamHI digestion, and an approximately 5.3-kbp linear fragment was isolated, treated with the Klenow enzyme, and then selfligated. The plasmid pHV1ÁB thus obtained had only one BamHI site near the multi-cloning sites. The BamHI fragments obtained from AA2M02 and AA2M14, containing the ETR101 and E2F1 genes together with the yeast ADHI promoter and terminator, were inserted into the BamHI sites of pHV1ÁB to yield pHV02B and pHV14B respectively.
Plasmid YEpITR1Z, having the E. coli lacZ gene fused to the yeast ITR1 gene, was described previously. 19) YEpITR1Z was digested with PstI and the approximately 3-kbp DNA fragment thus obtained was inserted into the PstI site of YEpM4 to yield M4Z. Plasmid TOPOhI1p was digested with EcoRI and then treated with the Klenow enzyme. An approximately 1-kbp DNA fragment was isolated and inserted into the SmaI site of M4Z to yield M4ZhI1p. A series of plasmids, having different lengths of the human INO1 promoter region fused to lacZ, was constructed as follows: Using plasmid TOPOhI1p as template, an approximately 100-bp DNA fragment of the INO1 promoter region was amplified by PCR with primers 5 0 -CCAGCGCGGGAGAGGCGG-3 0 (hI1pro-100) and hINO-B. The PCR product thus obtained was cloned into pCR2.1-TOPO. Then an approximately 100-bp DNA fragment excised with EcoRI was treated with the Klenow enzyme and inserted into the SmaI site of M4Z to yield p103Z. Similarly, approximately 200-and 300-bp DNA fragments of the INO1 promoter region were amplified by PCR, 5 0 -TGGACGCCTGGCCACTTC-3 0 (hI1pro-200) plus hINO-B and 5 0 -GCCTCATTGTCCTCTTGT-AAAGG-3 0 (rmICRE-1) plus hINO-B were used respectively, and cloned into the pTAC-1 vector (DynaExpress TA PCR Cloning Kit; BioDynamics Laboratory, Toky, Japan). After digestion with SmaI plus BamHI and treatment with the Klenow enzyme, approximately 200-and 300-bp DNA fragments were inserted into the SmaI site of M4Z to yield p203Z and p295Z respectively.
Plasmid pADANS-GFP is a 2-mm DNA-based vector containing the green fluorescein protein (GFP) gene and the LEU2 gene as a selectable marker. 20) Plasmid pIER-GFP, expressing GFP-fused ETR101 protein, was constructed as follows: An approximately 0.6-kbp coding region of ETR101 was amplified by PCR with primers 5 0 -GCGGCCGCATGGAAGTGCAGAAAGAG-3 0 and 5 0 -GCGGCC-GCAGAAGGCCACCACGGCCCG-3 0 , and plasmid AA2M02 as template. The PCR product thus obtained was then cloned into the pCR2.1-TOPO vector to yield pTO-NIN. Plasmid pTO-NIN was digested with NotI and inserted into the NotI site of pADANS-GFP to yield pIER-GFP.
For expression of ETR101 protein in E. coli cells, pET-IER was constructed as follows: An approximately 0.9-kbp DNA fragment of the ETR101 gene was amplified by PCR with primers 5 0 -AAGCTTCC-ATGGAAGTGCAGAAAG-3 0 and 5 0 -GCGGCCGCGTTCACGTCCC-AGTCCAC-3 0 , and plasmid AA2M02 as template. The approximately 0.9-kbp DNA fragment thus obtained was cloned into pCR2.1-TOPO to yield plasmid pTOPO-IER. Plasmid pTOPO-IER was then digested with HindIII and NotI, and an approximately 0.9-kbp DNA fragment containing the ETR101 gene was inserted between the HindIII and NotI sites of pET32a (CN Bioscience Inc.) to yield pET-IER.
-Galactosidase assay. -Galactosidase was assayed at 30 C by measuring the increase in absorbance at 420 nm with o-nitrophenyl--D-galactoside as the substrate after the cells had been permeabilized with chloroform and sodium dodecyl sulphate (SDS), as described previously. 21) Expression of ETR101 protein in E. coli cells and Western blot analysis. Overnight cultures of E. coli cells harboring plasmid pET-IER were diluted in fresh medium and then grown for a further 2 h at 37 C. Protein expression was induced with 1 mM isopropyl-1-thio--Dgalactopyranoside (IPTG), and after a further 3 h of growth, the cells were harvested by centrifugation and resuspended in 100 mM phosphate buffer (pH 7.5) containing 300 mM NaCl. The cells were then lysed by sonication and centrifuged at 11;000g for 10 min. The supernatant was used as the crude extract. The protein concentration of the lysate was determined with a Protein Assay Rapid Kit (Wako Pure Chemicals, Osaka, Japan). Extract containing about 60 mg of proteins were used in the gel-shift assay. The extracts were also subjected to SDS-polyacrylamide gel electrophoresis (12% gel). ETR101 protein was detected by staining with Coomassie Brilliant Blue or Western blotting. Western blotting detection was carried out as follows: Proteins separated by polyacrylamide gel electrophoresis were transferred to a nylon membrane (Hybond-C, Amersham, Piscataway, NJ), and the proteins expressed were determined with an anti-His tag antibody (Boeringer Mannheim, Mannheim, Germany) as the primary antibody and horse radish peroxidase-conjugated anti-mouse IgG (Promega, Madison, WI) as the secondary antibody. Blots were visualized using TMB membrane substrate detection solution (KPL, Gaithersburg, MD).
Electrophoretic mobility shift assay. Fluorescein isothiocyanate (FITC)-labeled DNA fragments were prepared as follows: The promoter region from À104 to À203 was amplified by PCR with primers hI1pro-200 and 5 0 -GAGGGAGGGGCCCAACGT-3 0 , with plasmid TOPOhI1p as template. The PCR product thus obtained was cloned into the pTAC-1 vector to yield plasmid pTAC-100/200. FITC-labeled oligo-nucleotide was amplified by PCR with primers hI1pro-101 and FITC-conjugated universal forward primer, viz., Fluorescein-Labeled Primer M4 (Takara Bio, Kyoto, Japan), and plasmid pTAC-100/200 as template. The FITC-labeled promoter regions from À1 to À103 and À204 to À295 were prepared in the same manner as for the FITC-labeled DNA fragment from À104 to 203, except that primers hINO-B plus hI1pro-100 and 5 0 -CGAGCGCGGCGCGTATAG-3 0 plus rmICRE-1 were used. The PCR-amplified DNA fragments were cloned into the pCR2.1-TOPO vector and used in the preparation of FITC-labeled DNA fragments.
DNA/protein reactions and electrophoretic mobility shift assays were performed using FITC-labeled probes, 2 mg of poly d(I-C), and 60 mg E. coli extracts in 5 mM HEPES-KOH (pH 7.8) buffer comprising 50 mM KCl, 5 mM MgCl 2 , 1mM EDTA, 10% glycerol, 25 mM dithiothreitol, 3.5 mM phenylmethylsulfony fluoride, and 10 mg/ml the pepstatin. DNA/protein complexes were separated on a 5% polyacrylamide gel in 89 mM Tris-HCl (pH 8), 89 mM boric acid, and 2 mM EDTA. FITC-labeled oligo-nucleotides separated in a gel were visualized with an Ettan DIGE Imager (GE Healthcare, Buckinghamshire, England).
Microscopic analysis. To investigate cell morphology, cells were grown to early log phase in minimal media containing histidine and choline. Images were taken under a scanning laser confocal imaging system (TCSSP2 AOBS; Leica, Wetslar, Germany).
Results
Functional analysis of the hINO1 promoter in yeast First we determined the hINO1 promoter activity in yeast using the E. coli lacZ reporter gene. As shown in Fig. 1 , we amplified an approximately 1-kbp hINO1 promoter region by PCR with human genomic DNA as template, and cloned it. Then the promoter region was fused to the E. coli lacZ reporter gene on a yeast multicopy vector. The plasmid M4ZhI1p thus obtained was introduced into the wild-type yeast strain (D452-2) , and the -galactosidase activity was compared with that of transformants harboring the promoter-less plasmid. As shown in Fig. 2A, - Fig. 1 ), to which Ino2p and Ino4p might bind. Hence, next we determined the effects of Ino2p and Ino4p on the hINO1 promoter activity using yeast disruptants. Unexpectedly, disruption of either INO2 or INO4 resulted in enhancement of the hINO1 promoter activity (Fig. 2B ). This evidence strongly suggests that the Ino2p/Ino4p complex functions as an inhibitory factor for the hINO1 promoter.
Construction of a yeast strain in which the PSS1 promoter was replaced with the hINO1 promoter
To isolate genes encoding proteins involved in the expression of hINO1, we next constructed a yeast strain containing the hINO1 promoter. As described under ''Materials and Methods,'' we constructed a DNA fragment of the hINO1 promoter region flanked by yeast PSS1 5 0 -noncoding regions, together with the URA3 gene as a selectable marker, by a method modified for the synthesis of marker cassettes with long flanking homology regions for gene disruption. 14, 15) The strain, PSShI1p, thus obtained grew on choline-containing media but not on choline-free media (Fig. 3) , suggesting that activation of the hINO1 promoter in yeast cells is not sufficient to support the expression of the PSS1 gene for its growth.
Next we screened human cDNAs, the products of which can activate the hINO1 promoter and support yeast cell growth on choline-free media. We used a human glioblastoma cDNA library constructed on a yeast expression vector. We obtained six transformants that grew on choline-free media. Isolation and sequence analysis of plasmids obtained from the transformants revealed that one plasmid contained cDNA for E2F1 and the other five contained the same cDNA, for ETR101. Reintroduction of these human cDNAs into yeast cells clearly supported the yeast strain, PSShI1p, on choline-free media, whereas the vector did not (Fig. 3) . It was also found that these transformants were inositol-sensitive, presumably because of hyper-repression of phosphatidylcholine synthesis by inositol.
13)
Human cDNAs support yeast cell growth via the hINO1 promoter
To examine the possibility that human cDNAs enhance yeast cell growth by activating a metabolic pathway that does not involve the PSS1 gene product, we used another yeast strain, PSS7. PSS7 has the same genotype as PSShI1p, except that the hINO1 promoter upstream of the PSS1 gene is replaced by the yeast GAL10 promoter. Hence PSS7 can grow on galactose media without choline but not on glucose media unless choline is supplied. The introduction of a human cDNA, E2F1 or ETR101, into the PSS7 strain did not support yeast cell growth on glucose (data not shown). This clearly indicates that human cDNA gene products support yeast cell growth via the hINO1 promoter, directly or indirectly.
Next we determined the effects of E2F1 and ETR101 on hINO1 promoter activity in yeast cells using the lacZ reporter assay. Plasmid M4ZhI1p containing the hINO1 promoter-lacZ fusion gene, together with an E2F1-expressing plasmid (pHV14B), an ETR101-expressing plasmid (pHV02B), and vector pHVÁB, was introduced into wild-type strain D452-2, and -galactosidase activities were compared. As shown in Fig. 4 , the A, Wild-type strain D452-2 was transformed with plasmid M4ZhI1p carrying the hINO1 promoter-lacZ fusion gene, with M4Z as a control vector. The transformants were cultured in minimal medium containing histidine and uracil with and without inositol, and after the cells reached early log phase, -galactosidase activities were measured. B, Plasmid M4ZhI1p was introduced into wild-type strain D452-2 (WT), ino2-disrupted strain INO2H (Áino2), ino4-disrupted strain INO4H (Áino4), and ino2/ino4-double disrupted strain KUMI24 (Áino2Áino4). Wild-type strain D452-2 harboring vector M4Z alone (WT(v)) was used as a control. Transformants were cultured in minimal media containing uracil, and after the cells reached log phase, -galactosidase activities were measured. Each bar represents the mean activity for three independent transformants. Error bars indicate standard deviations.
introduction of human cDNAs into yeast cells clearly enhanced hINO1 promoter activity. Approximately 4-fold induction was observed in both cases.
Effects of Ino2p and Ino4p on human cDNA functions As described above, the Ino2p/Ino4p complex decreased the hINO1 promoter activity in yeast cells. Thus it might be possible that human cDNAs introduced into yeast cells prevent the inhibitory effect of the Ino2p/ Ino4p complex, resulting in stimulation of yeast cell growth. If this is the case, then yeast cells should be able to grow on choline-free media when either the INO2 or the INO4 gene is disrupted. We disrupted the chromosomal INO2 gene in the PSShI1p strain by replacement with the HIS3-disrupted INO2 gene fragment. The resulting strain, PhI-I2H, however, did not grow on choline-free media, suggesting that prevention of the inhibitory effect of Ino2p/Ino4p, if any, is not sufficient to enhance the hINO1 promoter, and hence not sufficient to support yeast cell growth on choline-free media (data not shown). Direct activation of the hINO1 promoter by human cDNA gene products might be essential for yeast growth.
Direct interaction of the ETR101 gene product with the hINO1 promoter regions
The E2F1 gene product is known to bind to the hINO1 promoter region and to activate hINO1 expression. 6) Hence we attempted to determine whether the ETR101 gene product would bind to the hINO1 promoter region by the gel-shift assay method. To this end, we first expressed the recombinant ETR101 protein in E. coli cells. Production of recombinant ETR101 protein in E. coli cells was induced by the addition of IPTG. SDSpolyacrylamide gel electrophoresis analysis clearly indicated production of the recombinant protein upon IPTG-induction, and since the recombinant protein produced was fused with a His-tag, it was confirmed on Western-blot analysis with anti-His tag antibodies (data not shown).
Next we generated three fluorescein-labeled doublestranded DNA fragments, encompassing À1 to À103, À104 to À203, and À204 to À295. The fluoresceinlabeled DNA and E. coli cell extracts were mixed and then subjected to electrophoretic mobility shift assay to identify specific protein-DNA complexes. As shown in Fig. 5 , all three DNA fragments shifted when mixed with E. coli extracts expressing ETR101 protein (lanes 3), but not when mixed with control extracts (lanes 2).
Subcellular localization of ETR101 protein
Since the ETR101 gene product was suggested to bind to and enhance the hINO1 promoter, we determined its subcellular localization as a fusion protein with green fluorescent protein (GFP). A GFP-tag was fused to the N-terminus of ETR101 protein. First we tested to determine whether this chimeric protein had the ability to enhance hINO1 promoter activity similarly to the original protein. We introduced plasmid pETR101-GFP into the PSShI1p strain and then determined yeast cell growth on choline-free media. As shown in Fig. 6A , Wild-type strain D452-2 was transformed with plasmid M4ZhI1p carrying the hINO1 promoter-lacZ fusion gene, together with plasmid pHV02B (ETR101), pHV14B (E2F1), or vector pHV1ÁB (vector). The transformants were pre-cultured in minimal media containing inositol and histidine. The cells were then washed twice with water and cultured further in fresh minimal media containing inositol and histidine. After they reached log phase, -galactosidase activities were measured. Each bar represents the mean activity for four independent transformants. Error bars indicate standard deviations.
cells expressing GFP-fused protein clearly grew on choline-free media, whereas ones with the vector alone did not, indicating that the GFP-tag does not abolish the ability of ETR101 protein. Next we determined the subcellular localization of the GFP-tagged protein in yeast cells by confocal microscopic analysis. Even though fluorescent signals were observed in both the cytoplasm and the nucleus, the signals in the nucleus were much stronger than those in the cytoplasm (Fig. 6B) . Under the same conditions, no signals of the GFP were detected in cells having the vector alone (data not shown), suggesting that the ETR101 protein exists in the nucleus.
Subclone analysis of hINO1 promoter regions
To narrow down the cDNA products-responsive region of the hINO1 promoter further, we generated three subclones having hINO1 promoter regions of different lengths fused to the E. coli lacZ reporter gene. These subclones, p103Z, p203Z, and p295Z, contained promoter regions from À1 to À103, to À203, and to À295 respectively. These plasmids, together with E2F1-or ETR101-expressing plasmid, were introduced into the wild-type yeast strain, and then -galactosidase activities were determined (Fig. 7) . In the cases of subclones p103Z and p295Z, weak induction was observed when human cDNA-expressing plasmids coexisted. On the other hand, more than 2-fold induction was observed when plasmid p203Z was determined with human cDNAs. Induction by the ETR101 protein was nearly identical to that by the E2F1 protein. Wild-type strain D452-2 was transformed with plasmids carrying hINO1 promoter regions of different lengths fused to the lacZ gene (p103Z, p203Z, and p295Z) together with plasmid pHV02B (ETR101), pHV14B (E2F1), or vector pHV1ÁB (vector). The transformants were pre-cultured in minimal media containing uracil. The cells were then transferred to fresh minimal media containing uracil. After the cells had reached log phase, -galactosidase activities were measured. Each bar represents the mean activity for four independent transformants. Error bars indicate standard deviations.
Discussion
Among the short-lived growth factor-inducible genes, so called immediate early responsible genes, pip92 was isolated, sequenced, and reported in 1990. A human pip92 homolog, ETR101, was also reported in 1991. Since then, many studies on their regulation and promoter regions have been performed, but little is known about the functions of the encoded proteins. Here we identified the functioning of the ETR101 gene product as a transcription factor for the human myoinositol 1-phosphate synthase gene, hINO1.
Seelan et al. have presented evidence that E2F1 binds to and activates the promoter of hINO1. 6) We first determined that the hINO1 promoter exhibited some activity in yeast cells. Though yeast has no protein structurally related to E2F1, 22) it has proteins that bind to E2F-motifs and enhance promoters containing the E2F-motif in yeast cells. Vemu and Reichel identified an activity in an S. cerevisiae extract that exhibits the same DNA binding specificity as the mammalian E2F transcription factor and interacts with E2F-site promoter elements. 23) This factor, termed SCELA (Saccharomyces cerevisiae E2F-like activity), has a molecular weight of 47 kDa and is perhaps the DNA binding moiety of a large 300-kDa protein complex. Another report described the detection of a 12-kDa protein in S. cerevisiae 24) and a 30-kDa fission yeast protein, 25) which also interact with E2F elements, but the molecular properties of these factors have not yet been elucidated. It is conceivable that proteins similar to SCELA function in our case of the hINO1 promoter, but this activation of the hINO1 promoter was not sufficient to support the growth of yeast cells in which expression of the chromosomal PSS1 gene was under the control of the hINO1 promoter. Strain PSShI1p cannot grow on choline-free media when no human cDNA exists in the yeast cells.
Using the promoter-modified yeast strain, we screened human cDNAs, the products of which enhanced the hINO1 promoter, and hence supported yeast cell growth. We obtained two cDNAs, E2F1 and ETR101. Since the E2F1 gene product has been reported to be a transcription activator for hINO1, as mentioned above, the fact that we obtained E2F1 by the yeast screening system confirms that our screening system works well. It is also noteworthy that we obtained one clone having cDNA for E2F1 and five clones having cDNA for ETR101. We used a human glioblastoma cDNA library in screening. This strongly suggests that glioblastoma cells express ETR101 mRNA at a significant level.
A rat homolog of ETR101, pip92 protein, was first found to be present in the cytoplasm in cell fractionation, 7) and then it was found that the pip92 protein is selectively expressed in the nucleus as a fusion protein with GFP, 12) but no data have been presented. Here, we found that the GFP-fused ETR101 protein is expressed in the yeast nucleus by confocal microscopy, though the signal was also observed in the cytoplasm to some extent.
Seelan et al. identified the region from À1 to À156 as the E2F1-responsible minimal promoter region of hINO1.
6) They also found about 7-fold, 12-fold, and 8-fold induction by E2F1 in HeLa cell when promoter regions extending to À156, À261, and À387 were used, respectively. These results imply the loss of negative elements modulating E2F1-inducibility between À387 and À262, and the loss of positive E2F1-response elements between À261 and À157. These results are consistent with our data obtained with yeast cells (Fig. 7) . When our data are combined with those of Seelan et al., it can be proposed that negative elements exist between À295 and À262, and positive elements between À156 and À104. It is remarkable that negative elements, which might be present between À295 and À262, function in both HeLa cells and yeast cells. As mentioned by Seelan et al., a GATA element exists between À295 and À262. Yeast is known to have transcriptional regulators, such as Gln3 and Gat1, which bind to GATA elements, like mammalian GATA factors. In both mammalian and yeast cells, it has been reported that GATA binding factors function as inhibitory factors as well as activating factors for several promoters. 26, 27) 
